Yehezkel Ben-Ari

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: National Institute of Health and Medical Research, Université´ D'aix-Marseille, B&a Therapeutics. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yehezkel Ben-Ari. Retrieved from https://idiyas.com/inventor/yehezkel-ben-ari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 80.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Marseilles, FR (2016)
La Ciotat, FR (2017 - 2019)

Company Filing History:

4 out of 1,853

National Institute of Health and Medical Research

patents

4 out of 237

Université´ D'aix-Marseille

Centre Hospitalier Universitaire De Brest

patents

6. 1 out of 23

Centre Hospitalier Universitaire De Nantes

patents

7. 1 out of 147

Fondazione Istituto Italiano Di Tecnologia

The University of Nantes

patents

where one patent can have more than one assignee

Years Active: 2016-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10201507 - Modulators of intracellular chloride concentration for treating fragile X syndrome (2019-02-12),

2. 9974763 - Modulators of intracellular chloride concentration for treating neurodegenerative diseases with Parkinsonian Syndromes (2018-05-22),

3. 9822368 - Modulators of intracellular chloride concentration for treating down syndrome (2017-11-21),

4. 9592214 - Compounds for the treatment of autism in a baby child (2017-03-14),

5. 9415028 - Compounds for the treatment of autism (2016-08-16),

Title: Yehezkel Ben-Ari: Innovator in Neurodegenerative Disease Treatments

Introduction: Yehezkel Ben-Ari is a prominent inventor based in La Ciotat, France, known for his significant contributions to the field of medical research. He holds a total of five patents, focusing primarily on innovative treatments for neurodegenerative diseases and genetic disorders.

Latest Patents: Among his latest patents is a composition for treating Fragile X syndrome, which includes an effective amount of a modulator of a chloride transporter. Additionally, he has developed a composition aimed at treating neurodegenerative diseases with Parkinsonian syndromes, also utilizing a modulator of a chloride transporter.

Career Highlights: Yehezkel has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Aix-Marseille. His work has been pivotal in advancing therapeutic options for patients suffering from complex neurological conditions.

Collaborations: Throughout his career, Yehezkel has collaborated with notable colleagues, including Eric Lemonnier and Diana Carolina Ferrari. These partnerships have enriched his research and contributed to the development of his innovative solutions.

Conclusion: Yehezkel Ben-Ari's work exemplifies the impact of innovation in the medical field. His dedication to improving treatments for neurodegenerative diseases and genetic disorders continues to inspire future research and development in this critical area.

Profile summary based on public USPTO records.